These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 5231698)

  • 1. Modification of group B in acute myeloid leukaemia.
    Undevia JV; Bhatia HM; Sharma RS; Parekh JG
    Indian J Med Res; 1966 Dec; 54(12):1145-9. PubMed ID: 5231698
    [No Abstract]   [Full Text] [Related]  

  • 2. A case of modified A antigen in acute leukaemia.
    Antoni A; Case J
    Med J Malaysia; 1974 Jun; 28(4):290-2. PubMed ID: 4278976
    [No Abstract]   [Full Text] [Related]  

  • 3. [Analogy of the affinity between a B antigen, modified by leukemia in an A1B subject, and a partial B antigen induced by a Cis A1B chromosome].
    Salmon C; Jacquet A; Kling C; Salmon D
    Nouv Rev Fr Hematol; 1967; 7(5):755-64. PubMed ID: 4230114
    [No Abstract]   [Full Text] [Related]  

  • 4. Distribution of the ABO and Rh D blood groups in patients with leukemia.
    Gurda M; Turowska B
    Pol Med Sci Hist Bull; 1970 Apr; 13(2):89-91. PubMed ID: 4990468
    [No Abstract]   [Full Text] [Related]  

  • 5. Erythrocyte membrane modification in malignant diseases of myeloid and lymphoreticular tissues. I. Tn-polyagglutination in acute myelocytic leukaemia.
    Bird GW; Wingham J; Pippard MJ; Hoult JG; Melikian V
    Br J Haematol; 1976 Jun; 33(2):289-94. PubMed ID: 1063594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Changes of the antigenic determinants of the ABO system during a course of acute leukemia].
    Susaković N; Dinić B
    Bilt Hematol Transfuz; 1976; 4(1-2):109-16. PubMed ID: 60100
    [No Abstract]   [Full Text] [Related]  

  • 7. [Case of acute myelogenous leukemia with alteration in the blood type].
    Taguchi H; Sanada H; Katayama S; Nomura M; Takahashi Y
    Naika; 1970 Apr; 25(4):776-80. PubMed ID: 5268894
    [No Abstract]   [Full Text] [Related]  

  • 8. [A transient change in the ABO blood group in a case of acute myeloblastic leukemia].
    Nagasaki F; Kimoto M; Yamaguchi H; Asai I; Tsukada T
    Rinsho Ketsueki; 1974 Dec; 15(12):1333-8. PubMed ID: 4533901
    [No Abstract]   [Full Text] [Related]  

  • 9. Does donor-recipient ABO incompatibility protect against relapse after allogeneic bone marrow transplantation in first remission acute myeloid leukemia?
    Mehta J; Powles R; Sirohi B; Treleaven J; Kulkarni S; Saso R; Tait D; Singhal S
    Bone Marrow Transplant; 2002 May; 29(10):853-9. PubMed ID: 12058235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Modification of the "A" antigen during leukemia].
    Dazzi L; Ghindini O
    Riv Emoter Immunoematol; 1965; 12(1):52-60. PubMed ID: 5223657
    [No Abstract]   [Full Text] [Related]  

  • 11. Change in blood group phenotype.
    Balachandran V; Nair PM; Prasad K
    J Indian Med Assoc; 1996 Apr; 94(4):151, 153. PubMed ID: 8854634
    [No Abstract]   [Full Text] [Related]  

  • 12. [A transient change in the blood group accompanied by the decreased activity of A transferase in a case of acute myeloid leukemia].
    Kagawa H; Nasu K; Niki Y; Hoshizaki H; Yamaguchi H; Seno T
    Rinsho Ketsueki; 1986 Aug; 27(8):1369-75. PubMed ID: 3467096
    [No Abstract]   [Full Text] [Related]  

  • 13. Influence of HLA, ABO, and Rh(D) on survival after remission in acute myelogenous leukaemia.
    Harris R; Zuhrie SR; Taylor GM; Freeman CB; Wentzel J; Geary C; MacIver JE
    Lancet; 1977 Sep; 2(8039):653. PubMed ID: 71463
    [No Abstract]   [Full Text] [Related]  

  • 14. Change in the ABO blood group phenotype.
    Satheesh P; Thomas M; Rajan GB
    J Assoc Physicians India; 1994 Oct; 42(10):830. PubMed ID: 7876059
    [No Abstract]   [Full Text] [Related]  

  • 15. Determination of blood group specific substances A and B Hemagglutination inhibition technic/methodical aspects.
    Knoop J
    Z Immunitatsforsch Exp Klin Immunol; 1974 Apr; 146(5):389-95. PubMed ID: 4282987
    [No Abstract]   [Full Text] [Related]  

  • 16. Concurrent ABO blood type change and erythrophagocytosis by leukemic cells in a case of acute myeloblastic leukemia.
    Yamada K; Yoshizaki Y; Fujii Y; Inoue M; Ishida Y; Shinohara K; Kaneko T; Hiroshige Y; Matsumoto N
    Nihon Ketsueki Gakkai Zasshi; 1985 Sep; 48(6):1409-13. PubMed ID: 3867214
    [No Abstract]   [Full Text] [Related]  

  • 17. Distribution of ABO blood groups in childhood acute leukemia.
    Alavi S; Ashraf H; Rashidi A; Hosseini N; Abouzari M; Naderifar M
    Pediatr Hematol Oncol; 2006 Dec; 23(8):611-7. PubMed ID: 17065136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Distribution of the ABO and Rh-D systems in leukemic patients].
    Gurda M; Turowska B
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1970; 94(4):303-8. PubMed ID: 4101120
    [No Abstract]   [Full Text] [Related]  

  • 19. [Acute myeloblastic leukemia with transient loss of A and H antigens of the red blood cells--a case report].
    Asai T; Ito K; Sugiura Y; O H; Fujioka S
    Rinsho Ketsueki; 1983 Jul; 24(7):881-6. PubMed ID: 6579320
    [No Abstract]   [Full Text] [Related]  

  • 20. Expression of blood group-like antigens on the T lymphocytes of acute leukaemia patients in remission.
    Pullen S; Hersey P
    Clin Exp Immunol; 1980 Feb; 39(2):403-10. PubMed ID: 6966993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.